MedPath
FDA Approval

Argatroban

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
December 31, 2018
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Argatroban(250 mg in 2.5 mL)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Argatroban

Product Details

NDC Product Code
42023-182
Application Number
ANDA091665
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS
Effective Date
February 9, 2023
Code: IY90U61Z3SClass: ACTIMQuantity: 250 mg in 2.5 mL
ALCOHOLInactive
Code: 3K9958V90MClass: IACT
SORBITOLInactive
Code: 506T60A25RClass: IACT
© Copyright 2025. All Rights Reserved by MedPath